Table 2.
Antiretroviral regimen used for treatment initiation at Jos University Teaching Hospital
| Antiretroviral regime | Frequency | Percent |
| ABC-AZT-NVP | 24 | 0.2 |
| ABC-3TC-NVP | 270 | 1.9 |
| ABC-3TC-EFV | 29 | 0.2 |
| AZT-ddI-NVP | 110 | 0.8 |
| AZT-3TC-NVP | 5434 | 38.9 |
| AZT-3TC-EFV | 1035 | 7.4 |
| AZT-3TC-TDF | 172 | 1.2 |
| d4T-3TC-EFV | 33 | 0.2 |
| d4T-3TC-NVP | 2234 | 16.0 |
| d4T-TDF-FTC | 32 | 0.2 |
| ddI-3TC-EFV | 119 | 0.9 |
| ddI-3TC-NVP | 153 | 1.1 |
| TDF-3TC-EFV | 1673 | 12.0 |
| TDF-3TC-NVP | 2665 | 19.1 |
| Total | 13983 | 100.0 |
ABC, abacavir; AZT, zidovudine; 3TC, lamivudine; NVP, nevirapine; EFV, efavirenz; ddi, didanosine; TDF, tenofovir; FTC, entricitabine (often inter changeable with 3TC)